Richard Johnson
Finanzdirektor/CFO bei Phibro Animal Health (Belgium) SA
Profil
Richard G.
Johnson is currently the Chief Financial Officer at Phibro Animal Health (Belgium) SA. Previously, he held the same position at Phibro Animal Health Corp.
from 2002 to 2020.
Prior to that, he was the Vice President of Planning & Control at Ecolab, Inc. from 1992 to 1999 and the Director of Financial Management at Laserdyne Prima, Inc. from 2000 to 2002.
In 2023, he will return to Phibro Animal Health Corp.
as their Chief Financial Officer for a one-year term.
Aktive Positionen von Richard Johnson
Unternehmen | Position | Beginn |
---|---|---|
Phibro Animal Health (Belgium) SA
Phibro Animal Health (Belgium) SA Agricultural Commodities/MillingProcess Industries Phibro Animal Health SA (Belgium) manufactures animal health and nutrition products. The company's plant utilizes fermentation processes to produce the ingredients semduramicin-crystalline and virginiamycin; and also manufactures Stafac formulations. The company was founded in 2000 and is headquartered in Wavre, Belgium | Finanzdirektor/CFO | 08.06.2011 |
Ehemalige bekannte Positionen von Richard Johnson
Unternehmen | Position | Ende |
---|---|---|
PHIBRO ANIMAL HEALTH CORPORATION | Finanzdirektor/CFO | 09.02.2024 |
PHIBRO ANIMAL HEALTH CORPORATION | Finanzdirektor/CFO | 15.11.2020 |
Laserdyne Prima, Inc. | Corporate Officer/Principal | 01.01.2002 |
ECOLAB INC. | Corporate Officer/Principal | 01.01.1999 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
ECOLAB INC. | Process Industries |
PHIBRO ANIMAL HEALTH CORPORATION | Health Technology |
Private Unternehmen | 2 |
---|---|
Laserdyne Prima, Inc. | |
Phibro Animal Health (Belgium) SA
Phibro Animal Health (Belgium) SA Agricultural Commodities/MillingProcess Industries Phibro Animal Health SA (Belgium) manufactures animal health and nutrition products. The company's plant utilizes fermentation processes to produce the ingredients semduramicin-crystalline and virginiamycin; and also manufactures Stafac formulations. The company was founded in 2000 and is headquartered in Wavre, Belgium | Process Industries |